Tracking Parkinson's is supported by a number of invaluable research bodies. We are also collaborating with a growing number of partner studies.
If you are interested in collaborating or using Tracking Parkinson's data, please review our Data page.
Thank you for your support!
The NIHR's Clinical Research Network manages clinical research with NHS patients in England
The CSC, comprised of people affected by Parkinson's and researchers, provides guidance for long-term Parkinson's studies.
The CRN Portfolio supports researchers in developing, setting up and delivering high quality research to time and target in the NHS.
Partner projects that amplify the impact of our research
Led by Professor Dorothee Auer, the PaMIR study uses MRI technology to improve diagnosis of Parkinson’s and monitor the progression of the disease.
OPDC is led by Professor Michele Hu and Professor Richard Wade-Martins at the University of Oxford, focusing on the progress of Parkinson’s, prediction of onset, and using cell and animal models of the disease to test disease modifying treatments in an attempt to develop new therapies to slow the progression of Parkinson’s.
The Parkinson’s Families Project looks at genetic variations between those with Parkinson’s and their surrounding family in an attempt to pinpoint any relevant genetic variation responsible for the disease. The project is led by Professor Huw Morris at the Royal Free Hospital in London and University College London Institute of Neurology.
Based at the Imperial College London, and led by Dr Steve Gentleman, the Parkinson's UK Brain Bank obtains brain tissue from people with and without Parkinson's, which is used in multiple studies to increase our undertsanding of what causes Parkinson's, and how we may improve treatments for it.
CPP undertakes vital work in Parkinson’s research, and is led by Dr Diane Stephenson and Dr Arthur Roach. CPP analyses data from several studies, and our Tracking Parkinson's study is the biggest single contributor. The combining patient data is used to create models of disease progression, which improves the way in which new treatments can be developed for Parkinson's.
The IPDGC is an international collaboration of researchers that share expertise and front-line and extremely detailed genetic data to understand PD risk factors. The Tracking Parkinson's study has genetic findings on 7 million parts of each study participant's genetic code (DNA).
Led by Jean-Christophe Corvol, PRECISE-PD is a study based at INSERM in France, funded by France Parkinson. Tracking Parkinson's will serve as a validation cohort for their research.
Tracking Parkinson's will provide biosamples for the Global Parkinson's Genetics Program (GP2) under the Aligning Science Across Parkinson's (ASAP) program. Along with other cohorts, GP2 will undertake whole-genome sequencing and other analyses of thousands of our biosamples and combine this new genetic data with clinical data, creating a research resource with enormous global potential.
Print 